Nerve Growth Factor Induces the Expression of Chaperone Protein Calreticulin in Human Epithelial Ovarian Cells

Abstract

Epithelial ovarian cancer is highly angiogenic and high expression of Nerve Growth Factor (NGF), a proangiogenic protein. Calreticulin is a multifunctional protein with anti-angiogenic properties and its translocation to the tumor cell membrane promotes recognition and engulfment by dendritic cells. The aim of this work was to evaluate calreticulin expression in human normal ovaries, benign and borderline tumors, and epithelial ovarian cancer samples and to evaluate whether NGF regulates calreticulin expression in human ovarian surface epithelium and in epithelial ovarian cancer cell lines. Calreticulin mRNA and protein levels were analyzed using RT-PCR, Western blot and immunohistochemistry in 67 human ovarian samples obtained from our Institution. Calreticulin expression induced by NGF stimulation in cell lines was evaluated using RT-PCR, Western blot and immunocytochemistry. We found a significant increase of calreticulin mRNA levels in epithelial ovarian cancer samples as compared to normal ovaries, benign tumors, and borderline tumors. Calreticulin protein levels, evaluated by Western blot, were also increased in epithelial ovarian cancer with respect to benign and borderline tumors. When HOSE and A2780 cell lines were stimulated with Nerve Growth Factor, we found an increase in calreticulin protein levels compared to controls. This effect was reverted by GW441756, a TRKA specific inhibitor. These results suggest that NGF regulates calreticulin protein levels in epithelial ovarian cells through TRKA receptor activation.

Key words

cancer - ovary - CRT - NGF - TRKA - COE

• References

• 1 Ries L, Kosary C, Hankey B, Miller B, Edwards B. SEER Cancer Statistics. Review 1973–1995. Bethesda, MD: National Cancer Institute; 1998
• 2 Chen V, Ruiz B, Killeen J, Coté T, Wu X, Correa C. Pathology and Classification of Ovarian Tumors. Cancer Suppl 2002; 97: 2631-2642
• 3 Neufeld G, Cohen T, Gengrinivich S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13: 9-22
• 4 Campos X, Muñoz Y, Selman A, Yazigi R, Moyano L, Weinstein-Oppenheimer C, Lara H, Romero C. Nerve growth factor and its high-affinity receptor TrkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer. Gynecol Oncol 2007; 104: 168-175
• 5 Tapia V, Gabler F, Muñoz M, Yazigi R, Paredes A, Selman A, Vega M, Romero C. Tyrosine kinase A receptor (trkA): A potential marker in epithelial ovarian cancer. Gynecol Oncol 2011; 121: 13-23
• 6 Skaper S. The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol Disord Drug Targets 2008; 7: 46-62
• 7 Salas C, Julio-Pieper M, Valladares M, Pommer R, Vega M, Mastronardi C, Kerr B, Ojeda S, Lara H, Romero C. Nerve Growth Factor-dependent activation of trkA receptors in the human ovary results in synthesis of Follicle-Stimulating Hormone Receptors and Estrogen Secretion. J Clin Endocrinol Metab 2006; 91: 2393-2406
• 8 Dissen G, Hill D, Costa M, Les Dees C, Lara H, Ojeda S. A role for trkA nerve growth factor receptors in mammalian ovulation. Endocrinology 1996; 137: 198-209
• 9 Cantarella G, Lempereur L, Presta M, Ribatti D, Lombardo G, Lazarovici P, Zappalà G, Pafumi C, Bernardini R. Nerve growth factor–endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J 2002; 16: 1307-1309
• 10 Julio-Pieper M, Lozada P, Tapia V, Vega M, Miranda C, Vantman D, Ojeda S, Romero C. Effects of nerve growth factor (NGF) on blood vessels area and expression of the angiogenic factors VEGF and TGFbeta1 in the rat ovary. Reprod Biol Endocrin 2006; 4: 1-11
• 11 Julio-Pieper M, Lozada P, Tapia V, Vega M, Miranda C, Vantman D, Ojeda S, Romero C. Nerve growth factor induces vascular endothelial growth factor expression in granulosa cells via a trkA receptor/mitogen-activated protein kinase-extracellularly regulated kinase 2-dependent pathway. J Clin Endocrinol Metab 2009; 94: 3065-3071
• 12 Michalak M, Groenendyk M, Szabo J, Gold E, Opas L. Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem J 2009; 417: 651-666
• 13 Pike S, Yao L, Jones K, Cherney B, Appella E, Sakaguchi K, Nakhasi H, Teruya-Feldstein J, Wirth P, Gupta G, Tosato G. Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesisand Suppresses Tumor Growth. J Exp Med 2349-2356
• 14 Pike S, Yao L, Setsuda J, Jones KD, Cherney B, Appella E, Sakagichi K, Nakhasaki H, Teruya-Feldstein J, Wirth P, Gupta G, Tosato G. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 1999; 94: 2461-2468
• 15 Clarke C, Smyth M. Calreticulin exposure increases cancer immunogenicity. Nat Biotechnol 2008; 25: 192-193
• 16 Yao L, Pike S, Setsuda J, Parekh J, Gupta G, Raffeld M, Jaffe E. Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12. Blood 2002; 96: 1900-1905
• 17 Obeid M, Panaretakis T, Tesniere A, Joza N, Tufi R, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G. Leveraging the Immune System during Chemotherapy: Moving Calreticulin to the Cell Surface Converts Apoptotic Death from Silent to Immunogenic. Cancer Res 2007; 67: 7941-7944
• 18 Gardai S, Mcphillips K, Frasch S, Janssen W, Starefeldt A, Murphy-Ullrich J, Bratton D, Oldenborg P, Michalak M, Henson P. Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through trans-Activation of LRP on the Phagocyte. Cell 2005; 123: 321-334
• 19 Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund A, Chapman D, Durchschlag M, Joza N, Pierron G, Endert P, Yuan J, Zitvogel L, Madeo F, Williams D, Kroemer G. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 2009; 28: 578-590
• 20 Maines-Bandiera S, Kruk P, Auersperg N. Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am J Obstet Gynecol 1992; 167: 729-735
• 21 Kohan K, Carvajal R, Gabler F, Vantman D, Romero C, Vega M. Role of the transcriptional factors FOXO1 and PPARG on gene expression of SLC2A4 in endometrial tissue from women with polycystic ovary síndrome. Reproduction 2010; 140: 123-131
• 22 Qiu Y, Michalak M. Transcriptional control of the calreticulin gene in health and disease. Int J Biochem Cell Biol 2009; 41: 531-538
• 23 Groenendyk J, Michalak M. Endoplasmic reticulum quality control and apoptosis. Acta Biochim Pol 2005; 53: 381-395
• 24 Chen C, Chnag C, Su T, Hsu W. Identification of Calreticulin as a Prognosis Marker and Angiogenic Regulator in Human Gastric Cancer. Ann Surg Oncol 2009; 16: 524-533
• 25 Michalak M, Milner R, Burns K, Opast M. Calreticulin. Biochem J 1992; 285: 681-692